Bioprojet SCR-Product Pipeline Review-2015

Bioprojet SCR-Product Pipeline Review-2015

  • Products Id :- GMDHC06976CDB
  • |
  • Pages: 27
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Bioprojet SCR-Product Pipeline Review-2015


Global Markets Direct's, 'Bioprojet SCR-Product Pipeline Review-2015', provides an overview of the Bioprojet SCR's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Bioprojet SCR's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Bioprojet SCR including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Bioprojet SCR's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Bioprojet SCR's pipeline products

Reasons To Buy

Evaluate Bioprojet SCR's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Bioprojet SCR in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Bioprojet SCR's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Bioprojet SCR and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Bioprojet SCR

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Bioprojet SCR and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Bioprojet SCR Snapshot 5

Bioprojet SCR Overview 5

Key Information 5

Key Facts 5

Bioprojet SCR-Research and Development Overview 6

Key Therapeutic Areas 6

Bioprojet SCR-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Bioprojet SCR-Pipeline Products Glance 10

Bioprojet SCR-Late Stage Pipeline Products 10

Pre-Registration Products/Combination Treatment Modalities 10

Phase III Products/Combination Treatment Modalities 11

Bioprojet SCR-Clinical Stage Pipeline Products 12

Phase II Products/Combination Treatment Modalities 12

Phase I Products/Combination Treatment Modalities 13

Bioprojet SCR-Drug Profiles 14

pitolisant 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

dexecadotril 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

BP-1.4979 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

BP-1.3656 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

Bioprojet SCR-Pipeline Analysis 19

Bioprojet SCR-Pipeline Products by Target 19

Bioprojet SCR-Pipeline Products by Route of Administration 20

Bioprojet SCR-Pipeline Products by Molecule Type 21

Bioprojet SCR-Pipeline Products by Mechanism of Action 22

Bioprojet SCR-Recent Pipeline Updates 23

Bioprojet SCR-Dormant Projects 24

Bioprojet SCR-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Appendix 26

Methodology 26

Coverage 26

Secondary Research 26

Primary Research 26

Expert Panel Validation 26

Contact Us 26

Disclaimer 27

List of Tables

Bioprojet SCR, Key Information 5

Bioprojet SCR, Key Facts 5

Bioprojet SCR-Pipeline by Indication, 2015 7

Bioprojet SCR-Pipeline by Stage of Development, 2015 8

Bioprojet SCR-Monotherapy Products in Pipeline, 2015 9

Bioprojet SCR-Pre-Registration, 2015 10

Bioprojet SCR-Phase III, 2015 11

Bioprojet SCR-Phase II, 2015 12

Bioprojet SCR-Phase I, 2015 13

Bioprojet SCR-Pipeline by Target, 2015 19

Bioprojet SCR-Pipeline by Route of Administration, 2015 20

Bioprojet SCR-Pipeline by Molecule Type, 2015 21

Bioprojet SCR-Pipeline Products by Mechanism of Action, 2015 22

Bioprojet SCR-Recent Pipeline Updates, 2015 23

Bioprojet SCR-Dormant Developmental Projects,2015 24

Bioprojet SCR, Subsidiaries 25

List of Figures

Bioprojet SCR-Pipeline by Top 10 Indication, 2015 7

Bioprojet SCR-Pipeline by Stage of Development, 2015 8

Bioprojet SCR-Monotherapy Products in Pipeline, 2015 9

Bioprojet SCR-Pipeline by Top 10 Target, 2015 19

Bioprojet SCR-Pipeline by Top 10 Molecule Type, 2015 21

Bioprojet SCR-Pipeline Products by Top 10 Mechanism of Action, 2015 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Current R&D Portfolio of BIOPROJET SCR; BIOPROJET SCR - Key Therapeutics; BIOPROJET SCR - Pipeline Overview and Promising Molecules; BIOPROJET SCR - News; BIOPROJET SCR - Latest Updates; BIOPROJET SCR - Pipeline; BIOPROJET SCR - Discontinued/Dormant Projects

select a license
Single User License
USD 1500 INR 107340
Site License
USD 3000 INR 214680
Corporate User License
USD 4500 INR 322020



I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]